A meta-analysis of randomized controlled trials on the use of suction drains following rectal surgery. Dig Surg 2018; 35: 482–490.
Published: 6th February 2019
Authors: Guerra F, Giuliani G, Coletta D, Boni M, Rondelli F, Bianchi PP et al.
The analysis included 760 trials from four RCTs. Drains did not reduce postoperative leak (odds ratio 0.99), reintervention (OR 0.84) or death, but did increase the risk of postoperative bowel obstruction (OR 1.61).Pubmed Link
You may also be interested in
Robotic versus laparoscopic minimally invasive surgery for rectal cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Surg 2018; 267: 1034-1046.
Authors: Prete FP, Pezzolla A, Prete F, Testini M, Marzaioli R, Patriti A et al.
Tattooing improves the detection of small lymph nodes and increases the number of retrieved lymph nodes in patients with rectal cancer who receive preoperative chemoradiotherapy: a randomized controlled clinical trial. Am J Surg 2018; 215: 563-569.
Authors: Okada K, Sahahiro S, Ogimi T, Miyakita H, Saito G, Tanaka A et al.
Robot-assisted versus laparoscopic surgery for rectal cancer: a phase II open label prospective randomized controlled trial. Ann Surg 2018; 267: 243-251.
Authors: Kim MJ, Park SC, Park JW, Chang HJ, Kim DY, Nam B-H et al.
Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer. The ROLARR randomized clinical trial. JAMA 2017; 318: 1569-1580.
Authors: Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J et al.
Biological mesh closure of the pelvic floor after extralevator abdominoperineal resection for rectal cancer; a multicenter randomized controlled trial (the BIOPEX study). Ann Surg 2017; 265: 1074-1081.
Authors: Musters G, Klaver CE, Bosker RJI, Burger JWA, van Duijvendijk P, van Etten B et al.
Biological mesh closure of the pelvic floor after extralevator abdominoperineal resection for rectal cancer: a multicenter randomized controlled trial (the BIOPEX-study). Ann Surg 2017; 265: 1074-1081.
Authors: Musters G, Klaver CEL, Bosker R, Burger J, van Duijvendijk P, van Etten B et al.
To drain or not to drain infraperitoneal anastomosis after rectal excision for cancer: The GRECCAR 5 randomized trial. Ann Surg 2017; 265: 474-480.
Authors: Denost Q, Rouanet P, Faucheron J-L, Panis Y, Meunier B, Cotte E et al.
Male sexual dysfunction after rectal cancer surgery: results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212. Eur J Surg Oncol 2016; 42: 1851–1858.
Authors: Saito S, Fujita S, Mizusawa J, Kanemitsu Y, Saito N, Kinugasa Y et al.
Diverting ileostomy versus no diversion after low anterior resection for rectal cancer: a prospective, randomized, multicenter trial. Surgery 2016; 159: 1129–1139.
Authors: Mrak K, Uranitsch F, Pedross F, Heuberger A, Klinger A, Jagoditsch M et al.
Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer. The ALaCaRT Randomized Clinical Trial. JAMA 2015; 314: 1356-1363.
Authors: Stevenson ARL, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ et al et al.
Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes. The ACOSOG Z6051 Randomized Clinical Trial. JAMA 2015; 314: 1346-1355.
Authors: Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M et al. et al.
Biosorbable staple line reinforcement in restorative proctectomy and anterior resection: a randomized study. Dis Colon Rectum 2014; 57: 323-330.
Authors: Senagore A, Lane FR, Lee E, Wexner S, Dujovny N, Sklow B et al. et al.